Rockwell Medical investor relations material

Listen to the latest call from Rockwell Medical

Rockwell Medical, Inc., biopharmaceutical company, targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. It offers dialysis concentrates/dialysates and manufactured drugs, including Triferic (ferric pyrophosphate citrate), an iron replacement product for hemodialysis; Calcitriol injection, a vitamin D analog; Soluble Ferric Pyrophosphate (SFP) injection to treat iron deficient anemia; Rockwell's GranuFlo powder for oral solution; and Hematogenix SV Dialysis tests.

  • Ticker

  • Country


Dig deeper into the Rockwell Medical fundamentals on Quartr.